FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Xarelto News

Most Popular Xarelto Story

FDA asks for more data on Xarelto

The FDA issued a complete response letter for Bayer and Johnson & Johnson's potential blockbuster anti-clotting drug Xarelto (rivaroxaban). The agency declined to approved the drug, requesting... Read more...

Latest Headlines